No Data
No Data
Leerink Partners Maintains CVS Health(CVS.US) With Buy Rating, Maintains Target Price $75
Analysts Offer Insights on Healthcare Companies: CVS Health (CVS), Solid Biosciences (SLDB) and Moderna (MRNA)
Wall Street Today: Market Had Us in the First Half, Not Gonna Lie
Live Stock News: Apple Pulling $500B For U.S. AI, But is it Enough to Move the Needle
Notable Healthcare Headlines for the Week: UnitedHealth, Moderna, Sanofi in Focus
Is Trump Tariff Chaos Worrying Americans? Consumer Confidence Dips Amid Rising Inflation